Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT01642966
Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
56
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Completed
NCT01642940
Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study
30
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Acute Coronary Syndrome
Completed
NCT00454662
Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
5,141
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Hypertension
Cardiovascular Disease
Diabetes
Completed
NCT01201772
Prasugrel Re-load Strategies
65
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Completed
NCT01115738
Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
282
Enrollment(s)
3
Study location(s)
Interventional (Phase II)
Acute Coronary Syndrome
Completed
NCT01053026
Evaluation of Effects of Exercise Training and ARB in DM Patients
15
Enrollment(s)
1
Study location(s)
Observational
Vascular Function
Exercise Training
Completed
NCT00996281
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
837
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT01430091
A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet
18
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Sickle Cell Disease
91
92
93
94
95